1. Home
  2. TFSL vs ZLAB Comparison

TFSL vs ZLAB Comparison

Compare TFSL & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • ZLAB
  • Stock Information
  • Founded
  • TFSL 1938
  • ZLAB 2013
  • Country
  • TFSL United States
  • ZLAB China
  • Employees
  • TFSL N/A
  • ZLAB N/A
  • Industry
  • TFSL Savings Institutions
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFSL Finance
  • ZLAB Health Care
  • Exchange
  • TFSL Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • TFSL 3.5B
  • ZLAB 3.0B
  • IPO Year
  • TFSL 2007
  • ZLAB 2017
  • Fundamental
  • Price
  • TFSL $14.38
  • ZLAB $26.67
  • Analyst Decision
  • TFSL Hold
  • ZLAB Strong Buy
  • Analyst Count
  • TFSL 2
  • ZLAB 4
  • Target Price
  • TFSL $14.00
  • ZLAB $52.50
  • AVG Volume (30 Days)
  • TFSL 301.3K
  • ZLAB 1.1M
  • Earning Date
  • TFSL 10-30-2024
  • ZLAB 11-12-2024
  • Dividend Yield
  • TFSL 7.85%
  • ZLAB N/A
  • EPS Growth
  • TFSL 7.69
  • ZLAB N/A
  • EPS
  • TFSL 0.28
  • ZLAB N/A
  • Revenue
  • TFSL $304,660,000.00
  • ZLAB $355,748,000.00
  • Revenue This Year
  • TFSL N/A
  • ZLAB $48.50
  • Revenue Next Year
  • TFSL $6.83
  • ZLAB $47.37
  • P/E Ratio
  • TFSL $51.00
  • ZLAB N/A
  • Revenue Growth
  • TFSL N/A
  • ZLAB 35.01
  • 52 Week Low
  • TFSL $11.70
  • ZLAB $13.48
  • 52 Week High
  • TFSL $15.25
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 68.42
  • ZLAB 41.98
  • Support Level
  • TFSL $14.06
  • ZLAB $27.74
  • Resistance Level
  • TFSL $14.53
  • ZLAB $32.15
  • Average True Range (ATR)
  • TFSL 0.30
  • ZLAB 1.36
  • MACD
  • TFSL 0.14
  • ZLAB -0.64
  • Stochastic Oscillator
  • TFSL 91.80
  • ZLAB 3.15

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: